Uploaded November 2024 | Updated September 2026, 2 hours ago
Seminar Title: Precision Medicine for the Heart: pioneering technologies for diagnosing, treating and curing dilated cardiomyopathy
October 24, 2024 - The Steinmetz lab develops genomic technologies to study the genetic basis of complex phenotypes, the mechanisms of gene regulation, and the molecular systems underpinning disease. We’re leveraging biological insights across scales and organisms to predict, diagnose, treat and ultimately prevent disease.
While technological advances have enabled the association of thousands of genetic variants to complex traits of health and disease, we lack a comprehensive understanding of how genetic variation governs phenotypic diversity and disease. This is largely due to the challenge of discovering the mechanisms through which genetic variation shape cellular phenotypes, as well as the complex interplay between variants and the impact of environmental factors. The Steinmetz Lab's research is directed at developing genomics technologies and approaches to study the molecular processes that underlie complex genetic traits, gene regulation, and inherited diseases. Their approach has been to drive technology development together with biological application, in which they work across the broad axis of fundamental to translational research.
About the National Human Genome Research Institute (NHGRI) Division of Intramural Research (DIR) Seminar Series: The NHGRI DIR Seminar Series sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience.
Relevant Links:
DIR Seminar Series: genome.gov/dir/seminars
Lars Steinmetz at Stanford Medicine: https://www.med.stanford.edu/profiles/lars-steinmetz
Seminar Title: Precision Medicine for the Heart: pioneering technologies for diagnosing, treating and curing dilated cardiomyopathy
October 24, 2024 - The Steinmetz lab develops genomic technologies to study the genetic basis of complex phenotypes, the mechanisms of gene regulation, and the molecular systems underpinning disease. We’re leveraging biological insights across scales and organisms to predict, diagnose, treat and ultimately prevent disease.
While technological advances have enabled the association of thousands of genetic variants to complex traits of health and disease, we lack a comprehensive understanding of how genetic variation governs phenotypic diversity and disease. This is largely due to the challenge of discovering the mechanisms through which genetic variation shape cellular phenotypes, as well as the complex interplay between variants and the impact of environmental factors. The Steinmetz Lab's research is directed at developing genomics technologies and approaches to study the molecular processes that underlie complex genetic traits, gene regulation, and inherited diseases. Their approach has been to drive technology development together with biological application, in which they work across the broad axis of fundamental to translational research.
About the National Human Genome Research Institute (NHGRI) Division of Intramural Research (DIR) Seminar Series: The NHGRI DIR Seminar Series sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience.
Relevant Links:
DIR Seminar Series: genome.gov/dir/seminars
Lars Steinmetz at Stanford Medicine: https://www.med.stanford.edu/profiles/lars-steinmetz
